Centre tells states to act against unauthorised stem cell therapy
In an advisory issued on September 16, the ministry said stem cell therapy for autism spectrum disorder (ASD) must remain restricted to duly approved clinical trials.
Times of India1 source1 min readFiled September 17, 2026